Michael Recht
Pediatric Hematology-Oncology · New Haven, CTNPI 1366403164
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by CSL Behring at 31.6% of the total. Reporting peaked in 2019 at $88,992 and has fallen 76.6% since, to $20,867 in 2025.
Across 251 payments — averaging $1329.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$106K
- Genentech USA, Inc.$60K
- Shire North American Group Inc$57K
- HEMA Biologics, LLC$30K
- Pfizer$16K
- F. Hoffmann-la Roche AG$14K
- plus $51K from 9 others
Across 122 payments — averaging $6419.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$450K
- Spark Therapeutics, Inc.$119K
- Novo Nordisk AS$79K
- Bioverativ Therapeutics Inc.$45K
- Grifols Shared Services North America, Inc.$35K
- F. Hoffmann-la Roche AG$28K
- plus $27K from 3 others
What the payments were for
- Consulting fees$183,56955%
- Speaking & faculty fees$102,07231%
- Travel & lodging$36,14711%
- Food & beverage$6,7352%
- Education$5,0942%
- Gifts$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 74 | $105,514 |
| Genentech USA, Inc. | 33 | $60,061 |
| Shire North American Group Inc | 39 | $56,945 |
| HEMA Biologics, LLC | 53 | $30,067 |
| Pfizer | 4 | $16,156 |
| F. Hoffmann-la Roche AG | 3 | $13,603 |
| Sanofi-aventis U.S. LLC | 1 | $13,022 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $11,635 |
| Biomarin Pharmaceutical Inc. | 13 | $10,462 |
| Sanofi | 10 | $9,050 |
| Spark Therapeutics, Inc. | 4 | $3,650 |
| Regeneron | 3 | $1,977 |
| Octapharma USA, Inc. | 3 | $1,384 |
| Agios Pharmaceuticals, Inc. | 1 | $71 |
| Genentech, Inc. | 1 | $34 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few pediatric hematology-oncology providers in Connecticutto place this figure against a meaningful peer group, so we don't.
Other pediatric hematology-oncology in New Haven
- Prasanna AnanthNew Haven$23K
- Asher MarksNew Haven$7K
- Sarah ChirnomasNew Haven$2K
- Farzana PashankarNew Haven$2K
- Juan VasquezNew Haven$209
- Salley PelsNew Haven$191
- Aron FlaggNew Haven$106
- Stephanie MassaroNew Haven$0
- Nina Kadan LottickNew Haven$0
- Natalie BezlerHartford$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.